Logo

People in the News: Christopher Mitton

Dec 24, 2013
Premium

Cancer Genetics has hired Christopher Mitton as its new director of national account development and sales operations. Mitton previously headed North American sales of Qiagen's leukemia and solid tumor molecular tests. He has also held various sales positions at Ipsogen, Bayer HealthCare, Abbott Diagnostics, and BioChem Immunosystems.

Filed under

Diagnostics
Cancer Genetics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.